Skip to content
All bills in Congress

H.R. 2120 · 119th Congress · Health

ROCR Value Based Program Act

A bill that started in the House. To become law it must pass the House and the Senate in identical form and be signed by the President.

Where it stands

In committee in the House

  1. Introduced — doneMar 14, 2025
  2. Committee — not yet
  3. Passed the House — not yet
  4. Passed the Senate — not yet
  5. Sent to the President — not yet
  6. Became law — not yet

Latest action · Mar 14, 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

What this bill means

In plain English

This bill establishes a specialized payment program under Medicare for providers and suppliers of radiation oncology services.

From the official summary by the Congressional Research Service (introduced in house version). The full summary is below.

If it passes

It becomes federal law, and what it describes takes effect on the dates written into the bill.

What still has to happen

  1. 1A House committee must take it up and approve it. Most bills never get past this step.
  2. 2Then the full House must pass it.
  3. 3Then the Senate must pass it in the same form.
  4. 4Then it goes to the President to sign or veto.

If it doesn't pass

  • Nothing changes. The law stays exactly as it is today — a bill has no effect unless it is enacted.
  • This bill expires when the 119th Congress ends on Jan 3, 2027. To try again, a member would have to introduce it as a new bill in the next Congress and start over.
Read the full official summaryCongressional Research Service · Introduced in House · Mar 14, 2025

This bill establishes a specialized payment program under Medicare for providers and suppliers of radiation oncology services.

Specifically, the Centers for Medicare & Medicaid Services (CMS) must establish a program under which radiation therapy providers (i.e., hospital outpatient departments) and suppliers (i.e., physician group practices and freestanding radiation therapy centers) receive payments for each episode of care provided to individuals with specified types of cancer. An episode of care means the period beginning on the day radiation therapy planning is furnished to the individual and ending (1) for individuals with bone or brain metastases, 30 days later; and (2) for individuals with other cancer types, 90 days later.

Participation in the program is mandatory for providers and suppliers that participate in Medicare, unless the provider or supplier is part of a state-based Center for Medicare & Medicaid Innovation model or qualifies for a significant hardship exemption. The CMS must set payment rates for the program based on national payment rates with specified adjustments (e.g., geographic adjustments). Providers and suppliers who provide certain transportation services for individuals under their care may receive an additional payment. Providers and suppliers must be accredited in accordance with certain standards, subject to payment reductions.

The Government Accountability Office must report on (1) implementation of the program, and (2) underserved areas that are in need of more or newer radiation therapy resources.

Who started it

Sponsor — the member who introduced it

Brian K. Fitzpatrick

RepublicanRepresentative from Pennsylvania, District 1

Introduced in the House on Mar 14, 2025.

See Brian K. Fitzpatrick's votes and donors

Committees handling it

A bill is sent to the committee that covers its subject. The committee decides whether it ever reaches a vote of the full chamber.

  • Ways and Means Committee

    House

    • Referred To · Mar 14, 2025
  • Energy and Commerce Committee

    House

    • Referred To · Mar 14, 2025

Full timeline

Every recorded action on H.R. 2120, from the day it was introduced to the most recent, exactly as the House, the Senate, and the Library of Congress logged it.

  1. IntroducedHouse

    Introduced in House

  2. House

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Have a view on H.R. 2120? Your leaders vote on it.

Tell your senators and your representative where you stand. We fill in who represents you and reference this bill in the letter.

Write your leaders about thisSource: Congress.gov record for H.R. 2120(opens in new tab)